GHRP-6

Buy GHRP-6 — First-Generation Growth Hormone-Releasing Peptide

Researchers looking to buy GHRP-6 for laboratory study will find this synthetic hexapeptide is one of the original members of the GHRP class of growth hormone secretagogues. Developed in the 1980s, GHRP-6 acts as an agonist at the growth hormone secretagogue receptor (GHS-R1a) — the same receptor activated by endogenous ghrelin — and remains one of the most extensively researched reference compounds in ghrelin-pathway pharmacology. As a first-generation GHRP, it has served as the foundational reference for the development of later, more selective GHRPs such as Ipamorelin and Hexarelin.

Mechanism of Action

GHRP-6 has been investigated in published research for activity across several biological pathways, including:

• GHS-R1a receptor agonism — binding to the growth hormone secretagogue receptor in the pituitary and hypothalamus
• Ghrelin pathway signaling — research on the endogenous ghrelin pathway and downstream GH release mechanisms
• Pulsatile GH release — investigations into amplitude-modulated GH secretion patterns
• Appetite and feeding pathway research — studies on ghrelin-mediated appetite signaling in preclinical models, distinguishing GHRP-6 from later-generation GHRPs
• Cortisol and prolactin pathway research — comparative research on off-target hormonal effects associated with first-generation GHRPs
• Cardioprotective pathway research — preclinical investigations into GHS-R activity in cardiac tissue

GHRP-6 is distinguished in research literature as one of the first compounds in its class and has served as a foundational reference for the development of later, more selective GHRPs such as Ipamorelin. Unlike Ipamorelin, GHRP-6 is documented in published research to produce notable activity in the ghrelin/appetite pathway, making it a useful research tool when investigators specifically want to study ghrelin-pathway effects rather than isolated GH release.

Research Applications

GHRP-6 is widely used in research contexts including:

• GHS-R receptor pharmacology and signaling studies
• Ghrelin pathway and appetite-regulation research models
• Pulsatile GH release research
• Comparative analysis against Ipamorelin, GHRP-2, and Hexarelin
• Combined-pathway GH-axis research alongside GHRH analogs such as CJC-1295 and Tesamorelin
• IGF-1 response and downstream signaling research
• Cardioprotective pathway research in preclinical models

Product Specifications

• Compound: GHRP-6 (Growth Hormone-Releasing Peptide 6)
• Form: Lyophilized white powder
• Purity: ≥99% (verified by HPLC and mass spectrometry)
• Available sizes: 5mg
• Third-party tested: Certificate of Analysis available on request

Reconstitution & Storage

Lyophilized GHRP-6 should be stored at -20°C for long-term stability and protected from light. Once reconstituted with bacteriostatic water, the solution should be refrigerated at 2–8°C and used within the timeframe indicated on the product COA. Avoid repeated freeze-thaw cycles, as they can degrade peptide integrity.

Shipping & Handling

All orders are shipped with temperature-controlled packaging to preserve peptide integrity. Domestic orders typically arrive within 2–4 business days. Tracking is provided on every order.

Important Disclaimer

This product is sold strictly for laboratory research and in-vitro use only. It is not intended for human or animal consumption, diagnostic use, therapeutic use, or any form of clinical application. By purchasing, you confirm that you are a qualified researcher or affiliated with a licensed research institution and that this product will be handled in accordance with all applicable laws and safety standards.

GHRP-6 is not approved by the FDA for human use, and this product is not a substitute for any prescribed medication.